Oppenheimer & CO Inc 10x Genomics, Inc. Transaction History

Oppenheimer & CO Inc

$6.42 Billion
Q3 2024

A detailed history of Oppenheimer & CO Inc transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 17,294 shares of TXG stock, worth $247,477. This represents 0.01% of its overall portfolio holdings.

Number of Shares

17,294

Previous 24,039 28.06%

Holding current value

$247,477

Previous $467,000 16.49%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$15.71 - $23.49 $105,963 - $158,440	-6,745 Reduced 28.06%	17,294 $390,000
Q2 2024 Aug 07, 2024	BUY	$19.45 - $37.37 $261,719 - $502,850	13,456 Added 127.15%	24,039 $467,000
Q1 2024 May 06, 2024	SELL	$36.08 - $54.3 $127,614 - $192,059	-3,537 Reduced 25.05%	10,583 $397,000
Q4 2023 Feb 13, 2024	BUY	$34.32 - $57.55 $123,140 - $206,489	3,588 Added 34.07%	14,120 $790,000
Q3 2023 Nov 07, 2023	SELL	$40.86 - $62.98 $7,436 - $11,462	-182 Reduced 1.7%	10,532 $434,000
Q2 2023 Aug 02, 2023	SELL	$50.96 - $58.72 $7,389 - $8,514	-145 Reduced 1.34%	10,714 $598,000
Q1 2023 May 10, 2023	SELL	$35.33 - $55.79 $207,775 - $328,100	-5,881 Reduced 35.13%	10,859 $605,000
Q4 2022 Feb 07, 2023	SELL	$24.4 - $41.3 $80,032 - $135,464	-3,280 Reduced 16.38%	16,740 $610,000
Q3 2022 Nov 14, 2022	BUY	$28.48 - $52.59 $284,031 - $524,480	9,973 Added 99.26%	20,020 $570,000
Q2 2022 Aug 08, 2022	BUY	$36.95 - $82.41 $82,915 - $184,928	2,244 Added 28.76%	10,047 $455,000
Q1 2022 May 12, 2022	BUY	$55.7 - $145.79 $434,627 - $1.14 Million	7,803 New	7,803 $594,000

Others Institutions Holding TXG

# of Institutions

290

Shares Held

94.7M

Call Options Held

263K

Put Options Held

85.1K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.36B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Account

Oppenheimer & CO Inc 10x Genomics, Inc. Transaction History